TY - JOUR
T1 - Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy
AU - Wallace, Michael B.
AU - Crook, Julia E.
AU - Coe, Susan
AU - Ussui, Vivian
AU - Staggs, Estela
AU - Almansa, Cristina
AU - Patel, Mihir K.
AU - Bouras, Ernest
AU - Cangemi, John
AU - Keaveny, Andrew
AU - Picco, Michael
AU - Riegert-Johnson, Douglas
N1 - Funding Information:
DISCLOSURE: The following authors disclosed financial relationships relevant to this article: Dr Wallace has received research funding for this and other studies from Olympus , BSCI , Fujinon , Ninepoint Medical Rieger-Johnson , and Exact Sciences . Dr Almansa has received research grants from Olympus Inc . Dr Keaveny has received research grants from GlaxoSmithKline and Gilead Sciences . Dr Crook has received research grants from Boston Scientific , Olympus , GI Supply , and Masimo Corporation . Dr Bouras has received research grants from Rhythm Pharmaceuticals Inc . Dr Cangemi has received research grants from Abbott Laboratories . Dr Picco has received research grants from Pfizer . The study was funded by Olympus Corporation of America .
Publisher Copyright:
© 2014 by the American Society for Gastrointestinal Endoscopy.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Background Discriminating neoplastic from non-neoplastic polyps can significantly reduce the cost of colonoscopy. The American Society for Gastrointestinal Endoscopy (ASGE) recently set threshold levels for optical diagnostic accuracy to be acceptable for clinical use.Objective In this study, we compare a novel colonoscope capable of dual-focus imaging with standard colonoscopy with respect to the ASGE guidelines.Setting An academic medical center ambulatory surgical center.Patients and Interventions Patients at average risk were randomized to standard colonoscopy (Olympus CF-H180 and Exera II 180 colonoscopes, Olympus America, Center Valley, Pa) or dual-focus colonoscopy (Olympus CF-HQ190 and Exera III 190 colonoscopes, Olympus America). All polyps were given an optical diagnosis and compared with histology.Results A total of 600 patients were consented and 522 completed all aspects of the procedure. A total of 927 polyps were analyzed. Optical diagnostic accuracy was 79% (95% confidence interval, 74%-83%) for the 190 and 77% (95% confidence interval, 73%-81%) for the 180 colonoscope. Adenoma detection rates were also similar between the 2 groups (50% for the 190 vs 52% for the 180 colonoscope). For small distal rectosigmoid polyps with a high confidence diagnosis, the negative predictive value for adenoma was 96% (range 89%-99%) for the 180 in the narrow-band imaging (NBI) mode and 97% (range 88%-99%) for the 190 colonoscope in NBI mode. Agreement of surveillance intervals by using optical diagnosis was 94% to 95% for all modalities (180 and 190 colonoscopes, white light imaging, NBI).Limitations Our study evaluated the accuracy of the 180 and 190 colonoscopes at a center with already-established expertise in endoscopic imaging. Conclusions Both traditional and new dual-focus colonoscopes provide highly accurate optical polyp discrimination. There was no difference between the 2 systems in terms of discrimination or adenoma detection. Both systems are consistent with ASGE guidelines for optical diagnosis of selected colorectal polyps without histological confirmation.
AB - Background Discriminating neoplastic from non-neoplastic polyps can significantly reduce the cost of colonoscopy. The American Society for Gastrointestinal Endoscopy (ASGE) recently set threshold levels for optical diagnostic accuracy to be acceptable for clinical use.Objective In this study, we compare a novel colonoscope capable of dual-focus imaging with standard colonoscopy with respect to the ASGE guidelines.Setting An academic medical center ambulatory surgical center.Patients and Interventions Patients at average risk were randomized to standard colonoscopy (Olympus CF-H180 and Exera II 180 colonoscopes, Olympus America, Center Valley, Pa) or dual-focus colonoscopy (Olympus CF-HQ190 and Exera III 190 colonoscopes, Olympus America). All polyps were given an optical diagnosis and compared with histology.Results A total of 600 patients were consented and 522 completed all aspects of the procedure. A total of 927 polyps were analyzed. Optical diagnostic accuracy was 79% (95% confidence interval, 74%-83%) for the 190 and 77% (95% confidence interval, 73%-81%) for the 180 colonoscope. Adenoma detection rates were also similar between the 2 groups (50% for the 190 vs 52% for the 180 colonoscope). For small distal rectosigmoid polyps with a high confidence diagnosis, the negative predictive value for adenoma was 96% (range 89%-99%) for the 180 in the narrow-band imaging (NBI) mode and 97% (range 88%-99%) for the 190 colonoscope in NBI mode. Agreement of surveillance intervals by using optical diagnosis was 94% to 95% for all modalities (180 and 190 colonoscopes, white light imaging, NBI).Limitations Our study evaluated the accuracy of the 180 and 190 colonoscopes at a center with already-established expertise in endoscopic imaging. Conclusions Both traditional and new dual-focus colonoscopes provide highly accurate optical polyp discrimination. There was no difference between the 2 systems in terms of discrimination or adenoma detection. Both systems are consistent with ASGE guidelines for optical diagnosis of selected colorectal polyps without histological confirmation.
UR - http://www.scopus.com/inward/record.url?scp=84920160152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920160152&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2014.05.305
DO - 10.1016/j.gie.2014.05.305
M3 - Article
C2 - 24973171
AN - SCOPUS:84920160152
SN - 0016-5107
VL - 80
SP - 1072
EP - 1087
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 6
ER -